JP2023551122A5 - - Google Patents
Info
- Publication number
- JP2023551122A5 JP2023551122A5 JP2023528102A JP2023528102A JP2023551122A5 JP 2023551122 A5 JP2023551122 A5 JP 2023551122A5 JP 2023528102 A JP2023528102 A JP 2023528102A JP 2023528102 A JP2023528102 A JP 2023528102A JP 2023551122 A5 JP2023551122 A5 JP 2023551122A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- nk2r
- formula
- agonist according
- agonist
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20206509 | 2020-11-09 | ||
| EP20206509.0 | 2020-11-09 | ||
| PCT/EP2021/081057 WO2022096736A1 (en) | 2020-11-09 | 2021-11-09 | Compounds and their use in treatment of tachykinin receptor mediated disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023551122A JP2023551122A (ja) | 2023-12-07 |
| JP2023551122A5 true JP2023551122A5 (cg-RX-API-DMAC7.html) | 2024-10-30 |
Family
ID=73198203
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023528102A Pending JP2023551122A (ja) | 2020-11-09 | 2021-11-09 | 化合物およびタキキニン受容体介在性障害の治療におけるその使用 |
Country Status (13)
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3204051A1 (en) | 2021-01-20 | 2022-07-28 | Brian Lian | Compositions and methods for the treatment of metabolic and liver disorders |
| JP7642830B2 (ja) | 2021-09-15 | 2025-03-10 | バイキング・セラピューティクス・インコーポレイテッド | 代謝及び肝臓障害の処置のための組成物及び方法 |
| WO2023118263A1 (en) * | 2021-12-21 | 2023-06-29 | Embark Biotech Aps | Agonists for treatment of eating disorder |
| CN117384258B (zh) * | 2023-10-12 | 2024-07-26 | 湖南中晟全肽生物科技股份有限公司 | 一种神经激肽受体2（nk2r）激动剂及其应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2427475T3 (pl) * | 2009-05-08 | 2021-07-19 | Techfields Biochem Co., Ltd. | Kompozycje proleku o wysokim przenikaniu peptydów i związków powiązanych z peptydami |
| CN105722526B (zh) * | 2013-11-15 | 2020-12-08 | 诺和诺德股份有限公司 | 选择性pyy化合物及其用途 |
| TWI694082B (zh) * | 2015-06-12 | 2020-05-21 | 丹麥商諾佛 儂迪克股份有限公司 | 選擇性ｐｙｙ化合物及其用途 |
| WO2019059963A1 (en) * | 2017-09-21 | 2019-03-28 | Dignify Therapeutics, Llc | COMPOSITIONS FOR INDUCING MICTION AND DEFECATION |
| US11633459B2 (en) * | 2018-05-04 | 2023-04-25 | Novo Nordisk A/S | GIP derivatives and uses thereof |
| MX2022004566A (es) * | 2019-10-17 | 2022-07-21 | Univ Copenhagen | Agonista del receptor de taquiquinina 2 (tacr2). |
-
2021
- 2021-11-09 CN CN202180089751.3A patent/CN116745310A/zh active Pending
- 2021-11-09 KR KR1020237016448A patent/KR20230106616A/ko active Pending
- 2021-11-09 US US18/252,056 patent/US20230406883A1/en active Pending
- 2021-11-09 WO PCT/EP2021/081057 patent/WO2022096736A1/en not_active Ceased
- 2021-11-09 PE PE2023001563A patent/PE20231952A1/es unknown
- 2021-11-09 EP EP21802379.4A patent/EP4240749A1/en active Pending
- 2021-11-09 CA CA3197916A patent/CA3197916A1/en active Pending
- 2021-11-09 AU AU2021374843A patent/AU2021374843A1/en active Pending
- 2021-11-09 JP JP2023528102A patent/JP2023551122A/ja active Pending
- 2021-11-09 MX MX2023005408A patent/MX2023005408A/es unknown
- 2021-11-09 IL IL302745A patent/IL302745A/en unknown
-
2023
- 2023-05-08 CL CL2023001325A patent/CL2023001325A1/es unknown
- 2023-06-05 CO CONC2023/0007404A patent/CO2023007404A2/es unknown